Literature DB >> 990587

The inhibitory effect of gallamine on muscarinic receptors.

A L Clark, F Mitchelson.   

Abstract

1 The inhibitory effect of gallamine (1.1 muM-1.1 mM) on negative inotropic responses to acetylcholine (ACh) or carbachol (CCh) was investigated in isolated electrically stimulated atria of the guinea-pig. Gallamine caused parallel rightward shifts of the dose-response curves to the agonists, with no depression of the maximal response. 2 Gallamine (0.11 - 1.1 mM) produced a greater degree of antagnism towards CCh than towards ACh. With either agonist, the degree of antagonism produced by gallamine in high concentrations was less than that expected for a competitive antagonist.. 3 Similar findings were made when either negative inotropic or chronotropic responses were recorded in spontaneously beating guinea-pig atria. The inhibitory effect of gallamine against the negative inotropic response to cholinomimetics in electrically stimulated atria was not altered either in the presence of propranol (17 muM) or in atria obtained from guinea-pigs pretreated with diisopropylphosphorofluoridate (DEP) 12.5 mumol/kg, in divided doses over 3 days). 4 When ACh was used as the agonist, combination of gallamine with atropine (0.05-0.4 muM) produced dose-ratios which were less than expected for combination of two competitive antagonists. The same phenomenon was observed in atria obtained from guinea-pigs pretreated with DFP. 5 It is suggested that the antagonism produced by gallamine is a type of non-competitive inhibition, which has been termed "metaffinoid antagonism". An antagonist of this type allosterically alters the affinity of the agonist for its binding site, rather than changing the effectiveness of the agonist-receptor interaction.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990587      PMCID: PMC1667582          DOI: 10.1111/j.1476-5381.1976.tb07708.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  27 in total

Review 1.  THE INFLUENCE OF THE INTERVAL BETWEEN BEATS ON MYOCARDIAL CONTRACTILITY.

Authors:  J KOCH-WESER; J R BLINKS
Journal:  Pharmacol Rev       Date:  1963-09       Impact factor: 25.468

2.  THE UPTAKE OF ATROPINE AND RELATED DRUGS BY INTESTINAL SMOOTH MUSCLE OF THE GUINEA-PIG IN RELATION TO ACETYLCHOLINE RECEPTORS.

Authors:  W D PATON; H P RANG
Journal:  Proc R Soc Lond B Biol Sci       Date:  1965-08-24

3.  A theoretical basis of molecular pharmacology; II. Interactions of one or two compounds with two interdependent receptor systems.

Authors:  E J ARIENS; A M SIMONIS; J M VAN ROSSUM
Journal:  Arzneimittelforschung       Date:  1956-10

4.  The effect on the isolated rabbit heart of vagal stimulation and its modification by cocaine, hexamethonium and ouabain.

Authors:  L M MCEWEN
Journal:  J Physiol       Date:  1956-03-28       Impact factor: 5.182

5.  The inhibition of cholinesterases by antagonists of acetylcholine and histamine.

Authors:  A TODRICK
Journal:  Br J Pharmacol Chemother       Date:  1954-03

6.  The pharmacology of Flaxedil, with observations on certain analogs.

Authors:  W F RIKER; W C WESCOE
Journal:  Ann N Y Acad Sci       Date:  1951-10       Impact factor: 5.691

7.  The antagonism between cholinomimetic agonists and beta-adrenoceptor stimulants. The differentiation between functional and metaffinoid antagonism.

Authors:  J Offermeier; F G van den Brink
Journal:  Eur J Pharmacol       Date:  1974-07       Impact factor: 4.432

8.  An assessment of flaxedil (Gallamine triethiodide, B.P.).

Authors:  A G DOUGHTY; W D WYLIE
Journal:  Proc R Soc Med       Date:  1951-05

9.  The interaction of hemicholinium-3 (HC-3) with cholinomimetics and atropine.

Authors:  J Madden; F Mitchelson
Journal:  Eur J Pharmacol       Date:  1975-05       Impact factor: 4.432

10.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03
View more
  55 in total

Review 1.  Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.

Authors:  Gregory J Digby; Jana K Shirey; P Jeffrey Conn
Journal:  Mol Biosyst       Date:  2010-06-25

2.  Brain soluble fractions which modulate Na+, K+-ATPase activity likewise modify muscarinic receptor.

Authors:  G Rodríguez de Lores Arnaiz; P Schneider; C Peña
Journal:  Neurochem Res       Date:  1999-11       Impact factor: 3.996

Review 3.  G Protein-Coupled Receptors in Asthma Therapy: Pharmacology and Drug Action.

Authors:  Stacy Gelhaus Wendell; Hao Fan; Cheng Zhang
Journal:  Pharmacol Rev       Date:  2020-01       Impact factor: 25.468

4.  Muscarinic suppression of the M-current in the rat sympathetic ganglion is mediated by receptors of the M1-subtype.

Authors:  N V Marrion; T G Smart; S J Marsh; D A Brown
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

5.  A muscarinic view on Gq.

Authors:  Klaus Mohr; Christian Tränkle
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11       Impact factor: 3.000

Review 6.  Drugs and receptors. An overview of the current state of knowledge.

Authors:  T Kenakin
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

7.  Interaction of the neuromuscular blocking drugs alcuronium, decamethonium, gallamine, pancuronium, ritebronium, tercuronium and d-tubocurarine with muscarinic acetylcholine receptors in the heart and ileum.

Authors:  J Nedoma; N A Dorofeeva; S Tucek; S A Shelkovnikov; A F Danilov
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

Review 8.  Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.

Authors:  N T Burford; J R Traynor; A Alt
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

9.  Allosteric effect of gallamine on muscarinic cholinergic receptor binding: influence of guanine nucleotides and conformational state.

Authors:  T K Narayanan; R S Aronstam
Journal:  Neurochem Res       Date:  1986-10       Impact factor: 3.996

10.  Pharmacological characterization of acetylcholine-stimulated [35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies.

Authors:  S Lazareno; N J Birdsall
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.